Developer of a gene therapy technology designed for inherited retinal disorders. The company builds on proprietary Adeno-Associated Viral (AAV) vector platforms to address the gene therapy cargo capac...

Healthcare
Rome, Italy
Founded 2021
27 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$211.4M
Last Round
N/A